KEGG: sce:YLR136C
STRING: 4932.YLR136C
The TIS11 family consists of a small group of proteins that function in posttranscriptional gene regulation. In mammals, this family includes three main members: TIS11 (also known as ZFP36, TTP, Nup475, GOS24), TIS11b (Berg36, ERF-1, ZFP36L1, BRF-1), and TIS11d (ZFP36L2, ERF-2, BRF-2). A fourth member, Zfp36l3, has been identified in rodents but not in humans. TIS11-like proteins have also been identified in Drosophila and yeast .
The defining feature of all TIS11 family proteins is the presence of two tandemly repeated zinc finger motifs, which are critical for their function. These zinc fingers facilitate the binding of TIS11 proteins to adenine-uridine rich elements (AREs) in the 3' untranslated regions of target mRNAs. Once bound, TIS11 proteins promote the degradation of these mRNAs through a process known as ARE-mediated decay (AMD) .
It's important to note that TIS11 proteins function as part of a negative feedback mechanism in various cellular processes, including inflammatory responses and tissue regeneration. For example, in macrophages, activation of TNF-α signaling induces TIS11 expression, which then targets TNF-α mRNA for degradation, thereby resolving the inflammatory response .
TIS11 proteins regulate the stability of a substantial portion of the transcriptome, with studies suggesting they could influence up to 8-16% of all mRNAs in mammals and flies . This widespread impact on gene expression makes them central players in numerous biological processes.
In normal tissue homeostasis, TIS11 proteins are crucial for regulating stem cell proliferation rates. Research in Drosophila has demonstrated that TIS11 is required to re-establish basal proliferation rates of intestinal stem cells (ISCs) after a regenerative episode. TIS11 knockdown results in significantly larger stem cell clones, indicating increased proliferation, while overexpression dramatically reduces clone size, confirming TIS11's role in limiting stem cell proliferation .
Beyond normal physiology, dysregulation of TIS11 proteins has been implicated in inflammation, cancer, and other pathological conditions. Understanding the mechanisms by which these proteins control mRNA stability can provide insights into disease pathogenesis and potential therapeutic strategies.
When selecting or evaluating antibodies against TIS11 proteins, understanding their structural features is essential. The most conserved regions across TIS11 family members are the tandem CCCH zinc finger domains, which may lead to cross-reactivity among antibodies targeting these regions .
Outside the zinc finger domains, TIS11 proteins contain more divergent sequences that may serve as better targets for generating family member-specific antibodies. N-terminal and C-terminal regions show considerable variation between family members and can be targeted for specific recognition .
Researchers should also be aware that TIS11 proteins undergo various post-translational modifications, including phosphorylation, which can affect antibody recognition. For instance, phosphorylation may alter protein conformation or mask epitopes, potentially reducing antibody binding efficiency.
Selecting the appropriate antibody for TIS11 research requires careful consideration of several factors:
Specificity: Determine whether the antibody recognizes a single TIS11 family member or multiple members. Antibodies targeting conserved regions, such as the zinc finger domains, may cross-react with other family members.
Host species: Consider the host species in which the antibody was generated, especially in relation to the experimental design. For instance, the search results mention a rabbit anti-TIS11 antibody used in Drosophila studies .
Application compatibility: Verify that the antibody has been validated for your specific applications (Western blot, immunoprecipitation, immunofluorescence, etc.).
Epitope information: Understanding the specific epitope recognized by the antibody can help predict potential cross-reactivity and interpret experimental results.
Validation data: Review published studies that have used the antibody to assess its reliability. The antibody mentioned in the search results was effectively used for immunostaining in Drosophila guts .
When designing experiments involving TIS11 antibodies, researchers should include appropriate controls to verify specificity, such as knockout or knockdown samples, blocking peptides, or pre-immune serum controls.
Validating antibody specificity is crucial for obtaining reliable results in TIS11 research. A comprehensive validation approach should include:
Genetic models: Use tissues or cells with knocked-out or knocked-down TIS11 expression as negative controls. The search results describe using RNAi to knock down TIS11 expression, which could serve as a validation control .
Overexpression systems: Compare antibody signals between wild-type samples and those overexpressing TIS11 proteins. The search results mention several TIS11 overexpression constructs (UAS-TIS11, UAS-TIS11 Flag) that could be useful for this purpose .
Western blot analysis: Verify that the antibody detects bands of the expected molecular weight. For TIS11 family proteins, this varies by family member but is typically between 35-45 kDa.
Peptide competition: Pre-incubate the antibody with the immunizing peptide to confirm that this blocks specific binding.
Cross-reactivity testing: Test the antibody against all TIS11 family members to determine its specificity within the family.
In cases where multiple TIS11 family members are expressed in the same tissue, researchers may need to use complementary techniques, such as RNA in situ hybridization (as described in the search results) along with antibody staining, to confirm specificity .
Proper experimental controls are vital for accurate interpretation of TIS11 antibody results:
Negative controls: Include samples lacking TIS11 expression, such as TIS11 knockout tissue or cells transfected with TIS11 RNAi. The search results describe a TIS11 RNAi construct that could be used for this purpose .
Positive controls: Use samples with known TIS11 expression or those overexpressing TIS11 proteins. The search results mention UAS-TIS11 and UAS-TIS11 Flag constructs that could serve as positive controls .
Secondary antibody-only controls: Include samples processed with only secondary antibodies to assess non-specific binding.
Isotype controls: Use irrelevant antibodies of the same isotype to evaluate non-specific binding. The search results mention using Mouse IgG2A proteins as controls in immunoprecipitation experiments .
Cross-validation: When possible, validate findings using multiple antibodies targeting different epitopes of the same protein.
In studies examining TIS11 regulation of specific target mRNAs, include additional controls such as mutant versions of TIS11 lacking RNA-binding activity or mutated target mRNAs lacking TIS11 binding sites.
Several immunoassay techniques have proven effective for TIS11 protein detection, each with specific advantages depending on research objectives:
Western blotting: Useful for quantitative analysis of TIS11 protein levels and assessment of post-translational modifications. When performing Western blots for TIS11 proteins, using gradient gels (10-15%) can help resolve potential multiple bands resulting from post-translational modifications.
Immunofluorescence/Immunohistochemistry: Valuable for determining the spatial distribution of TIS11 proteins within tissues or cells. The search results describe a protocol for immunostaining Drosophila guts using TIS11 antibodies, which involves fixation in glutamic acid buffer followed by incubation with anti-TIS11 antibody at 1:500 dilution .
Immunoprecipitation (IP): Essential for studying TIS11 protein interactions or for RNA immunoprecipitation (RIP) experiments. The search results outline an RNA-immunoprecipitation protocol for TIS11 using anti-FLAG antibodies .
Flow cytometry: Useful for quantifying TIS11 expression in heterogeneous cell populations, particularly when combined with other cellular markers.
ELISA: Provides quantitative measurement of TIS11 proteins in solution, though less commonly used than the above techniques for research purposes.
Table 1: Comparison of immunoassay techniques for TIS11 detection
| Technique | Primary Application | Sensitivity | Key Considerations for TIS11 |
|---|---|---|---|
| Western blot | Protein quantification, modification analysis | Moderate | Use gradient gels; include phosphatase treatment if studying phosphorylation |
| Immunofluorescence | Subcellular localization | Moderate-High | Fixation method critical; use glutamic acid buffer for Drosophila tissues |
| Immunoprecipitation | Protein-protein or protein-RNA interactions | High | Crosslinking may be necessary for transient interactions |
| Flow cytometry | Cell population analysis | High | Permeabilization required for intracellular TIS11 detection |
| ELISA | Quantification in solution | Very High | Less common for research; mainly used in clinical settings |
TIS11 antibodies are instrumental in investigating ARE-mediated mRNA decay mechanisms through several approaches:
RNA immunoprecipitation (RIP): This technique allows for the identification of mRNAs directly bound by TIS11 proteins in vivo. The search results describe an RIP-Seq protocol where TIS11-FLAG was expressed along with Pop2 RNAi (to stabilize TIS11-bound messengers) and immunoprecipitated using anti-FLAG antibodies . This approach identified 320 RNAs reproducibly enriched in TIS11 pull-downs, of which 7 were directly regulated by TIS11 in intestinal stem cells .
Immunofluorescence combined with RNA FISH: Dual staining with TIS11 antibodies and fluorescent probes for target mRNAs can reveal the co-localization of TIS11 proteins with their target transcripts in processing bodies or stress granules. The search results mention a protocol for fluorescent RNA in situ hybridization in Drosophila guts that could be combined with TIS11 immunostaining .
Pulse-chase experiments: By combining TIS11 immunoprecipitation with metabolic labeling of RNA, researchers can track the kinetics of mRNA decay for specific TIS11 targets.
Crosslinking and immunoprecipitation (CLIP): This technique provides higher resolution mapping of TIS11 binding sites on target mRNAs than standard RIP.
When designing these experiments, it's critical to consider that TIS11 binding to target mRNAs may be transient and context-dependent. The search results indicate that TIS11 activity increases during tissue repair in Drosophila intestinal stem cells, suggesting that experimental timing is crucial for capturing relevant interactions .
Immunoprecipitation of TIS11 proteins requires careful optimization to maintain protein-RNA or protein-protein interactions while ensuring specific pulldown. Based on the search results and general best practices, here's an optimized protocol:
Sample preparation: Flash-freeze tissue in liquid nitrogen and homogenize in an appropriate lysis buffer. The search results describe using polysome lysis buffer for TIS11 immunoprecipitation from Drosophila tissues .
Antibody selection: Use either validated TIS11-specific antibodies or tag-specific antibodies (such as anti-FLAG) if working with tagged TIS11 constructs. The search results mention using 2.5 μg Mouse anti-FLAG antibodies for immunoprecipitation of FLAG-tagged TIS11 .
Bead preparation: Pre-coat Protein G or Protein A beads (depending on the antibody isotype) with specific antibodies or appropriate controls. The search results describe using Protein G Dynabeads coated with either Mouse anti-FLAG antibodies or Mouse IgG2A proteins as controls .
Immunoprecipitation: Incubate prepared beads with lysates under conditions that maintain the interactions of interest. For RNA-protein interactions, RNase inhibitors should be included.
Washes: Perform stringent washes to remove non-specifically bound material while preserving specific interactions.
Elution and analysis: Elute bound material and analyze by Western blotting, mass spectrometry, or RNA sequencing depending on experimental goals.
For RNA immunoprecipitation specifically, the search results describe a protocol where researchers expressed TIS11-FLAG along with Pop2 RNAi (to stabilize TIS11-bound messengers), performed immunoprecipitation, and then analyzed bound RNAs by sequencing . This approach successfully identified direct TIS11 targets in Drosophila intestinal stem cells.
TIS11 proteins play crucial roles in stem cell regulation and tissue regeneration, making antibodies against these proteins valuable tools for investigating these processes:
Tracking dynamic expression patterns: The search results demonstrate that TIS11 expression and activity increase in intestinal stem cells during tissue repair in Drosophila . Antibodies can be used to track these dynamic changes in expression levels and subcellular localization during regenerative processes.
Lineage tracing experiments: Combining TIS11 antibody staining with stem cell markers can reveal how TIS11 expression correlates with differentiation states. The search results mention using TIS11 antibodies alongside markers such as Delta (for intestinal stem cells) and Prospero (for enteroendocrine cells) .
Functional studies with genetic manipulation: The search results describe experiments where TIS11 was knocked down or overexpressed in stem cell lineages, followed by antibody staining to assess effects on proliferation and differentiation . TIS11 knockdown increased clone size (indicating increased proliferation), while overexpression reduced clone size to 1-2 cells (compared to an average of seven cells in controls) .
Identification of regulatory networks: TIS11 antibodies can be used in chromatin immunoprecipitation (ChIP) experiments to identify transcription factors that regulate TIS11 expression during regeneration, or in RIP experiments to identify mRNAs regulated by TIS11 in stem cells. The search results describe RIP-Seq experiments that identified 7 genes directly destabilized by TIS11 in Drosophila intestinal stem cells, including HLHm3, which affects stem cell proliferation .
These approaches can provide insights into how post-transcriptional regulation contributes to stem cell function and tissue regeneration, with potential implications for regenerative medicine.
Investigating TIS11-mediated regulation in disease models requires specialized methodological approaches:
Disease-specific tissue analysis: Use TIS11 antibodies to compare expression patterns between normal and diseased tissues. For inflammatory conditions, this could involve examining TIS11 expression in response to inflammatory stimuli. The search results mention that TIS11 expression is induced in response to infection in Drosophila intestinal stem cells .
Genetic manipulation in disease models: Combine disease models with TIS11 knockdown or overexpression to assess functional consequences. The search results describe using RNAi and overexpression constructs to manipulate TIS11 levels in Drosophila intestinal stem cells .
Target identification in disease contexts: Use RNA immunoprecipitation with TIS11 antibodies to identify disease-specific mRNA targets. The approach described in the search results, combining TIS11-FLAG expression with Pop2 RNAi to stabilize target mRNAs, could be applied to disease models .
Post-translational modification analysis: Use phospho-specific antibodies or general TIS11 antibodies combined with phosphatase treatment to examine how disease states affect TIS11 activity through post-translational modifications.
Therapeutic intervention studies: Evaluate how potential therapeutics affect TIS11 expression, localization, or activity using antibody-based detection methods.
In all these approaches, it's critical to include appropriate disease and control models, as TIS11 function appears to be highly context-dependent. The search results indicate that TIS11 limits stem cell proliferation specifically after proliferation has been stimulated in response to stress or infection, suggesting its activity is regulated by cellular context .
Combining TIS11 antibody-based techniques with other methodologies can provide more comprehensive insights into TIS11 function:
RIP-Seq/CLIP-Seq with transcriptome analysis: The search results describe using RNA immunoprecipitation followed by sequencing (RIP-Seq) to identify TIS11-bound mRNAs, combined with transcriptome analysis of TIS11-overexpressing or TIS11-deficient cells to identify functionally regulated targets . This combination revealed that only a subset of bound mRNAs (7 out of 44 detected in both experiments) were directly destabilized by TIS11 in intestinal stem cells .
Multi-omics approaches: Integrate antibody-based TIS11 protein analysis with transcriptomics, proteomics, and metabolomics to understand the broader impact of TIS11-mediated regulation on cellular physiology.
Live imaging techniques: Combine fixed-tissue antibody staining with live imaging of fluorescently tagged TIS11 or its targets to understand dynamic regulation.
Single-cell analysis: Use TIS11 antibodies in single-cell Western blot or mass cytometry approaches to examine cell-to-cell variation in TIS11 expression within heterogeneous populations.
In vivo reporter systems: Complement antibody staining with reporter constructs containing TIS11 binding sites to visualize TIS11 activity in living organisms.
Table 2: Integrated approaches for studying TIS11 function
| Integrated Approach | Primary Application | Key Insights Provided |
|---|---|---|
| RIP-Seq + Transcriptomics | Target identification | Distinguishes direct binding from functional regulation |
| Antibody staining + Live imaging | Dynamic regulation | Temporal and spatial patterns of TIS11 activity |
| IP-Mass Spectrometry + RIP-Seq | Regulatory complexes | Protein and RNA components of TIS11 regulatory machinery |
| ChIP-Seq + RIP-Seq | Transcriptional and post-transcriptional regulation | Coordination between mRNA production and decay |
| Antibody staining + Single-cell RNA-Seq | Cellular heterogeneity | Cell-specific roles of TIS11 regulation |
When facing contradictory results in TIS11 antibody experiments, a systematic analytical approach is essential:
Antibody validation reassessment: Confirm antibody specificity using knockout or knockdown controls. The search results describe TIS11 RNAi and null alleles that could be used as negative controls .
Context-dependent regulation: Consider that TIS11 function may be highly context-dependent. The search results indicate that TIS11 limits stem cell proliferation specifically after proliferation has been stimulated, not under basal conditions .
Post-translational modifications: Evaluate whether contradictions might stem from differential post-translational modifications affecting antibody recognition or TIS11 function.
Family member redundancy: Assess whether other TIS11 family members might compensate for loss of one member, confounding knockdown or knockout results.
Technical variables: Review experimental conditions such as fixation methods, antibody concentrations, and incubation times. The search results specify using 100 mM glutamic acid buffer with 4% formaldehyde for fixation and antibody incubation at 4°C .
Independent techniques: Validate key findings using complementary approaches. For example, if antibody staining suggests increased TIS11 expression, confirm with qPCR or Western blotting.
When reporting contradictory results, carefully document all experimental variables and consider that such contradictions may reveal important biological insights about context-dependent regulation of TIS11 proteins.
Researchers working with TIS11 antibodies commonly encounter several technical challenges:
Low signal intensity: TIS11 proteins are often expressed at low levels or in specific cellular contexts.
High background or non-specific staining: This is particularly problematic in tissues with endogenous biotin or peroxidase activity.
Cross-reactivity with other TIS11 family members: The conserved zinc finger domains may lead to antibody cross-reactivity.
Solution: Use antibodies targeting less conserved regions or validate specificity using overexpression of individual family members.
Post-translational modifications affecting epitope recognition: Phosphorylation or other modifications may mask antibody epitopes.
Solution: Use multiple antibodies targeting different epitopes or treat samples with appropriate phosphatases before analysis.
RNA-dependent interactions: Some protein-protein interactions involving TIS11 may be RNA-dependent.
Solution: For immunoprecipitation experiments, include conditions with and without RNase treatment to distinguish direct protein interactions from RNA-mediated associations.
Table 3: Troubleshooting guide for common TIS11 antibody issues
| Issue | Potential Causes | Troubleshooting Strategies |
|---|---|---|
| No signal in Western blot | Low expression, degradation, poor transfer | Use concentrated samples, add protease inhibitors, optimize transfer conditions |
| Multiple bands in Western blot | Post-translational modifications, proteolysis, cross-reactivity | Use phosphatase treatment, add protease inhibitors, include knockout controls |
| No signal in immunofluorescence | Epitope masking, improper fixation | Try different fixation methods, antigen retrieval, use tagged constructs |
| High background in immunofluorescence | Non-specific binding, autofluorescence | Increase blocking time, use different blocking agents, include secondary-only controls |
| Failed immunoprecipitation | Weak antibody binding, harsh buffer conditions | Try different antibodies, optimize buffer conditions, use tagged constructs |
Distinguishing between highly similar TIS11 family members presents a significant challenge. Here are methodological approaches to address this issue:
Epitope selection for antibody generation: Commission or select antibodies targeting non-conserved regions of specific TIS11 family members, particularly in N-terminal or C-terminal domains outside the conserved zinc finger motifs.
Validation with overexpression systems: Test antibody specificity by overexpressing individual TIS11 family members. The search results describe several TIS11 overexpression constructs that could be used for this purpose .
Knockout/knockdown controls: Use genetic models lacking individual TIS11 family members to validate antibody specificity. The search results mention TIS11 RNAi constructs and null alleles that could serve as controls .
Complementary RNA analysis: Combine protein detection with RNA analysis using member-specific probes. The search results describe a protocol for fluorescent RNA in situ hybridization using TIS11-specific probes .
Sequential immunoprecipitation: For samples containing multiple TIS11 family members, perform sequential immunoprecipitation with antibodies of different specificities to isolate individual members.
Mass spectrometry validation: Following immunoprecipitation, use mass spectrometry to confirm the identity of the precipitated TIS11 family member based on peptide sequences unique to each member.
When interpreting results, consider that multiple TIS11 family members may be co-expressed and could have redundant or distinct functions. The search results indicate that in Drosophila intestinal stem cells, TIS11 functions as a negative feedback regulator of proliferation , but other family members might have different roles in the same or different tissues.
The field of TIS11 antibody research is poised for several important advances in the coming years:
Development of highly specific monoclonal antibodies: Creating and validating antibodies that can reliably distinguish between TIS11 family members will enhance our understanding of their specific roles.
Antibodies targeting specific post-translational modifications: As our understanding of TIS11 regulation improves, antibodies recognizing specific phosphorylated forms or other modifications will become increasingly valuable.
Application to single-cell techniques: Adapting TIS11 antibodies for use in single-cell proteomics and spatial transcriptomics will reveal cell-type-specific functions and heterogeneity in TIS11 activity.
Therapeutic applications: As the role of TIS11 proteins in diseases becomes better understood, antibodies may serve as therapeutic agents or diagnostic tools.
Structural studies: Antibodies could be used to facilitate crystallization or cryo-EM studies of TIS11 proteins in complex with their target RNAs or protein partners.
The search results highlight the importance of TIS11 in regulating stem cell proliferation and tissue regeneration , suggesting that future studies may focus on its roles in regenerative medicine and cancer biology. The identification of specific mRNA targets through RIP-Seq approaches also opens new avenues for investigating the regulatory networks controlled by TIS11 proteins in different cellular contexts.
Integrating TIS11 antibody data with other molecular information requires a multi-layered approach:
Data integration platforms: Use bioinformatics tools to integrate antibody-based protein data with transcriptomics, epigenomics, and other omics datasets. The search results describe combining RIP-Seq and RNA-Seq data to identify direct TIS11 targets in intestinal stem cells .
Network analysis: Place TIS11 regulatory events within broader signaling networks. The search results indicate that TIS11 regulates components of key signaling pathways controlling intestinal stem cell proliferation, including JNK and BMP signaling .
Temporal dynamics: Capture the temporal dynamics of TIS11 expression, localization, and target binding during biological processes. The search results show that TIS11 activity increases during tissue repair and serves as a negative feedback mechanism to restore stem cell quiescence .
Multi-scale modeling: Develop mathematical models that incorporate TIS11-mediated post-transcriptional regulation within larger gene regulatory networks.
Collaborative approaches: Establish collaborations between researchers with expertise in different methodologies to build a more comprehensive understanding of TIS11 function.
By integrating antibody-based studies with other approaches, researchers can develop a more complete understanding of how TIS11 proteins coordinate post-transcriptional regulation in complex biological systems, with potential applications in understanding and treating diseases characterized by dysregulated RNA stability.